Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.13
-0.26 (-3.52%)
At close: Jan 9, 2026, 4:00 PM EST
7.06
-0.07 (-0.98%)
After-hours: Jan 9, 2026, 7:59 PM EST
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $48.36 million as of January 9, 2026. Its market cap has decreased by -65.88% in one year.
Market Cap
48.36M
Enterprise Value
53.61M
1-Year Change
-65.88%
Ranking
Category
Stock Price
$7.13
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $48.36M, a decrease of -98.08%. That is a compound annual growth rate of -56.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 48.36M | -35.18% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | 2.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |